Organigram Announces Executive Changes
February 02 2021 - 9:00AM
Business Wire
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President,
Operations, will be leaving Organigram at the end of May 2021 to
pursue other interests.
Organigram would like to thank Matt for his efforts helping
Organigram grow from a licensed producer of medical cannabis to one
of the country’s leading producers of both medical and adult use
recreational products.
One of Organigram’s earliest employees, “Matt has embraced the
challenges and opportunities of the cannabis industry. His insights
and creativity have been instrumental as we have worked to develop
a state-of-the-art production facility,” says Greg Engel, CEO,
Organigram.
Mr. Rogers has made many foundational contributions to the
organization and has been a key team member during Organigram’s
rapid growth. During his tenure, he led and oversaw initiatives
including the construction of the Company’s recently completed
edibles and derivative facility and the Company’s operational
strategy related to the Company’s “Rec 2.0” products. “We would
like to thank Matt for his commitment to a seamless transition and
wish him well in his future endeavours” said Greg Engel, CEO.
Matt will continue with Organigram full time until the end of
February 2021 and will support the team on a part-time basis until
the end of May 2021. During that time, Matt will work closely with
Nathalie Batten, Organigram’s newly named Plant Manager.
Nathalie joined the Organigram team as a consultant in
Operations in November 2020. Ms. Batten has recently held
senior-level positions including Director, Fleet and Operations as
well as Director, Blending and Packaging at Irving Oil, an
international refining and marketing company which operates
Canada’s largest refinery along with more than 900 fuelling
locations. There, Nathalie built high-performance teams and led the
development and execution of strategic business plans.
Prior to Irving Oil, Nathalie held various roles in business
development and strategy at Keyera Corporation which operates one
of the largest independent midstream energy companies in Canada and
at Tenaris, a leading manufacturer of pipes and related services
for the world’s energy industry.
Nathalie is a professional industrial engineer and has a Master
of Business Administration from University of Calgary and a
Bachelor of Mechanical Engineering from Queen’s University.
About Organigram Holdings
Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, SHRED and Trailblazer. Organigram's
facility is located in Moncton, New Brunswick and the Company is
regulated by the Cannabis Act and the Cannabis Regulations
(Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210202005704/en/
For Investor Relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries, please contact: Marlo Taylor
mtaylor@gagecommunications.ca
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024